Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (1682)	7/1/2003 5:40:11 PM
From: Madharry	Read Replies (1) of 3044

I wonder how many shares abt sold today-maybe thats why the stock price is declining. demand and supply. What this guy is saying may have some validity. On the other hand Millenium was valued for its genetic platform. Velcade has little to do with that- I wonder if its possible to quantify the potential value of Velcade alone based upon the jNJ deal. Would any care to hazard a calculated guess as to the agreed upon royalty? How will they market Velcade in the US? Once Velcade is approved in EUrope for MM, can it be prescibed by physicians for other cancerss? if it is does JNJ get a piece of that? It seems to me that is i am a cancer patient and have exhausted other alternatives. I am going to try velcade and not wait for a specific approval for my form of cancer.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next